BRPI0510946A - tratamento de asma em crianças - Google Patents

tratamento de asma em crianças

Info

Publication number
BRPI0510946A
BRPI0510946A BRPI0510946-9A BRPI0510946A BRPI0510946A BR PI0510946 A BRPI0510946 A BR PI0510946A BR PI0510946 A BRPI0510946 A BR PI0510946A BR PI0510946 A BRPI0510946 A BR PI0510946A
Authority
BR
Brazil
Prior art keywords
children
asthma treatment
asthma
treatment
glycopyrrolate
Prior art date
Application number
BRPI0510946-9A
Other languages
English (en)
Inventor
Susan Snape
Robin Mark Bannister
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of BRPI0510946A publication Critical patent/BRPI0510946A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

TRATAMENTO DE ASMAS EM CRIANçAS O glicopirrolato ou um análogo dele é útil no tratamento da asma em crianças.
BRPI0510946-9A 2004-05-10 2005-05-10 tratamento de asma em crianças BRPI0510946A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0410399.0A GB0410399D0 (en) 2004-05-10 2004-05-10 The treatment of respiratory disease
PCT/GB2005/001791 WO2005107873A2 (en) 2004-05-10 2005-05-10 Glycopyrrolate for treating childhood asthma

Publications (1)

Publication Number Publication Date
BRPI0510946A true BRPI0510946A (pt) 2007-11-20

Family

ID=32526760

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510946-9A BRPI0510946A (pt) 2004-05-10 2005-05-10 tratamento de asma em crianças

Country Status (15)

Country Link
US (1) US20070243260A1 (pt)
EP (1) EP1750807A2 (pt)
JP (1) JP2007536362A (pt)
KR (1) KR20070042917A (pt)
CN (1) CN1972730A (pt)
AU (1) AU2005240406A1 (pt)
BR (1) BRPI0510946A (pt)
CA (1) CA2565170A1 (pt)
GB (1) GB0410399D0 (pt)
IL (1) IL178816A0 (pt)
MX (1) MXPA06013040A (pt)
NO (1) NO20065536L (pt)
NZ (1) NZ550909A (pt)
WO (1) WO2005107873A2 (pt)
ZA (1) ZA200610264B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0410398D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0613161D0 (en) 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
WO2011039952A1 (ja) * 2009-09-30 2011-04-07 株式会社サンギ 難溶性物質の水溶解性改善方法
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
BR112012015334A2 (pt) 2009-12-23 2016-03-15 Chiesi Farma Spa terapia combinada para doença pulmonar obstrutiva crônica
MX340264B (es) 2009-12-23 2016-07-04 Chiesi Farm Spa Formulacion de aerosol para la enfermedad pulmonar obstructiva cronica.
PE20160853A1 (es) 2009-12-23 2016-09-14 Chiesi Farm Spa Terapia combinada para enfermedad pulmonar obstructiva cronica (epoc)
KR20120106753A (ko) 2009-12-23 2012-09-26 키에시 파르마슈티시 엣스. 피. 에이. Ｃｏｐｄ용 에어로졸 제제
JO3510B1 (ar) * 2011-03-04 2020-07-05 Heptares Therapeutics Ltd استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
JP5909796B2 (ja) 2012-03-02 2016-04-27 株式会社サンギ 難溶性物質の水溶解性改善方法
KR101995612B1 (ko) * 2012-03-14 2019-07-02 가부시키가이샤 엘티티 바이오파마 만성 폐색성 폐질환 개선제
WO2014062143A2 (en) * 2012-10-19 2014-04-24 Mahmut Bilgic Anticholinergic agent combinations
WO2014077787A1 (en) * 2012-11-16 2014-05-22 Mahmut Bilgic Combinations including abeta2 agonist and glycopyrrolate
BR112016014583B1 (pt) 2013-12-30 2022-12-20 Chiesi Farmaceutici S.P.A Composição de solução farmacêutica em aerossol, inalador pressurizado de dose calibrada e uso da dita composição
SG11201700536XA (en) 2014-09-09 2017-02-27 Vectura Ltd Formulation comprising glycopyrrolate, method and apparatus
KR20180082442A (ko) * 2015-11-16 2018-07-18 키에시 파르마슈티시 엣스. 피. 에이. 항콜린제, 코르티코스테로이드 및 베타-아드레날린성 약물을 포함하는 건조 분말 제제의 제조 방법
US10098837B2 (en) 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD
US12616654B2 (en) 2019-12-02 2026-05-05 Chiesi Farmaceutici S.P.A. Stainless steel can for pressurised metered dose inhalers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1283036T3 (da) * 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
AU2211502A (en) * 2000-11-30 2002-06-11 Vectura Ltd Method of making particles for use in a pharmaceutical composition

Also Published As

Publication number Publication date
IL178816A0 (en) 2007-05-15
ZA200610264B (en) 2008-06-25
NO20065536L (no) 2006-12-08
KR20070042917A (ko) 2007-04-24
GB0410399D0 (en) 2004-06-16
NZ550909A (en) 2011-02-25
US20070243260A1 (en) 2007-10-18
WO2005107873A3 (en) 2006-03-16
AU2005240406A1 (en) 2005-11-17
EP1750807A2 (en) 2007-02-14
CA2565170A1 (en) 2005-11-17
CN1972730A (zh) 2007-05-30
MXPA06013040A (es) 2007-02-12
WO2005107873A2 (en) 2005-11-17
JP2007536362A (ja) 2007-12-13

Similar Documents

Publication Publication Date Title
BRPI0312331A2 (pt) composições de ácido hialurônico e métodos de emprego.
NO20052058D0 (no) Behandling av influensa.
AT9566U3 (de) Kopierfräseinrichtung zur herstellung von zahntechnischen werkstücken
DE60213762D1 (de) Implementierung des SHA1 Algorithmusses
EP1567101A4 (en) PROPHYLACTIC TREATMENT METHODS
MA28985B1 (fr) Analogues de loxapine et methodes d'utilisation
NO20076206L (no) Kombinasjon av PDE4 inhibitor romflumilast og et tetrahydrobioterin-derivativ
SG163517A1 (en) Antiviral compounds and methods
NO20065536L (no) Behandling av astma hos barn
BRPI0510947A (pt) tratamento de doença respiratória
NO20055130D0 (no) Aminocykloheksyleter-forbindelser og deres anvendelse
NO20071378L (no) Tiazolo-naftylsyrer.
NO20043952L (no) Benzofuran- og benzotiofenderivater som er nyttige ved behandling av hyperproliferative forstyrrelser
JP2006502186A5 (ja) β-グルカンの使用
TW200716525A (en) Process for preparation of sulfamide derivatives
TW200630367A (en) Substituted adenines and the uses thereof
EP1976548A4 (en) VIP FRAGMENTS AND APPLICATION PROCEDURES
DE60330099D1 (de) Verfahren und Anordnungen zur Herstellung, Feststellung und Übertragung von Identifikatoren
EP1625567A4 (en) SYSTEM FOR USING THE WHITE KEYS OF MUSIC INSTRUMENT KEYBOARDS FOR SELECTED RANGES
IS7166A (is) Notkun annellataðra pýrrólsambanda í meðhöndlun áliðabrjósks- eða neðanbrjósksbeinahrörnun
WO2005117939A3 (en) Use of GPCR54 ligands for the treatment of infertility
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
GB2393571B (en) Improvements in and relating to the control of instruments
NO20053903D0 (no) Nukleotidlipidesterderivater.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/00 (2006.01), A61P 11/06 (2006.01), A61K 3